FdaApplication

NDA 017581

Back to search

Identifiers

Properties

PropertyValue
applicant_nameATNAHS PHARMA US LTD
application_typeNDA
approval_date1982-04-15

Products (3)

ProductActive ingredientStrengthDosage form
NAPROSYNNAPROXEN375MGTABLET;ORAL
NAPROSYNNAPROXEN500MGTABLET;ORAL
NAPROSYNNAPROXEN250MGTABLET;ORAL

3 products